SHP1 antibody (full length)

Catalog No. ABIN7878904

The Mouse Monoclonal anti-SHP1 antibody (Clone CPTC-PTPN6-2) (ABIN7878904) specifically detects SHP1 in WB. The antibody is reactive with Human samples.

Quick Overview for SHP1 antibody (full length) (ABIN7878904)

Target: SHP1 (PTPN6) (Protein-tyrosine Phosphatase 1C (PTPN6))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This SHP1 antibody is un-conjugated

Application: Western Blotting (WB)

Grade: Carrier-free

Clone: CPTC-PTPN6-2

Product Details anti-SHP1 Antibody

Binding Specificity: full length

Purpose: PTPN6 Antibody / SHP-1 (azide and preservative free)

Purification: Protein G affinity chromatography

Immunogen: Recombinant human full-length PTPN6 protein was used as the immunogen for the PTPN6 antibody.

Isotype: IgG2a, kappa

Application Details

Application Notes: Optimal dilution of the PTPN6 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: 4 °C,-20 °C

Storage Comment: Store the PTPN6 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Target Details for SHP1

Target: SHP1 (PTPN6) (Protein-tyrosine Phosphatase 1C (PTPN6))

Alternative Name: PTPN6

Background: PTPN6, which is also designated as SHP-1, is expressed primarily in hematopoietic cells and characterized by the presence of two SH2 domains N-terminal to the PTP domain. It maps to 12p13, a region commonly involved in leukemia-associated chromosomal abnormalities. SHP-1 plays a role in modulating intracellular signaling for various molecules. In T-cell lymphomas and other malignancies, SHP-1 phosphatase expression is lost, by a thus far undetermined mechanism. Preliminary studies suggest that it may be helpful in differentiating mantle/marginal zone lymphomas (SHP-1+) from follicular lymphomas (SHP-1 negative).

UniProt: P29350

Pathways: JAK-STAT Signaling, TCR Signaling, TLR Signaling, Nuclear Receptor Transcription Pathway, Positive Regulation of Peptide Hormone Secretion, Steroid Hormone Mediated Signaling Pathway, Response to Growth Hormone Stimulus, Regulation of Leukocyte Mediated Immunity, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, BCR Signaling